Amarin Corp PLC (NAS:AMRN)
$ 0.5578 0.0055 (1%) Market Cap: 229.44 Mil Enterprise Value: -72.52 Mil PE Ratio: 0 PB Ratio: 0.43 GF Score: 37/100

Q4 2018 Amarin Corporation PLC Earnings Call Transcript

Feb 27, 2019 / 12:30PM GMT
Release Date Price: $21.18 (+5.85%)
Operator

Welcome to Amarin Corporation's conference call to discuss its financial and operating results for the fourth quarter and full year 2018. This conference call is being recorded today, February 27, 2019.

I would like to turn the conference over to Elisabeth Schwartz, Senior Director, Investor Relations of Amarin.

Elisabeth Schwartz
Amarin Corporation plc - Senior Director of IR

Please be aware that this conference call will contain forward-looking statements that are intended to be covered under the Safe Harbor provided by the Private Securities Litigation Reform Act. Examples of such statements include, but are not limited to, our current expectations regarding our commercial and financial performance, including levels of Vascepa prescriptions, Vascepa product and licensing revenues, costs and other commercial metrics, gross margin, expenditures and the adequacy of our financial resources; our current expectations for scientific presentations, publications, regulatory reviews and related timing thereof; our expectations that REDUCE-IT results could

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot